Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer
Chenyi Luo, Peipei Wang, Siqi He, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
Onyinyechi Obidiro, Gantumur Battogtokh, Emmanuel O. Akala
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1796-1796
Open Access | Times Cited: 145
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 69
Short-chain fatty acids in cancer pathogenesis
Mark A. Feitelson, Alla Arzumanyan, Arvin Medhat, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 677-698
Open Access | Times Cited: 52
Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancer
Ashutosh Gupta, Kumar Nishchaya, Moumita Saha, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105401-105401
Open Access | Times Cited: 21
AMPK–a key factor in crosstalk between tumor cell energy metabolism and immune microenvironment?
Na Wang, Bofang Wang, Ewetse Paul Maswikiti, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 21
CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil
Fatemeh Nasiri, Mehrasa Kazemi, Seyed Mohamad Javad Mirarefin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
CAR-Macrophages and CAR-T Cells Synergistically Kill Tumor Cells In Vitro
Maoxuan Liu, Junchen Liu, Ziwei Liang, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3692-3692
Open Access | Times Cited: 44
Small molecule agents for triple negative breast cancer: Current status and future prospects
Yan Ou, Mengchao Wang, Qian Xu, et al.
Translational Oncology (2024) Vol. 41, pp. 101893-101893
Open Access | Times Cited: 13
Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments
Yan Zhuo, Zhengbo Zhang, Yanan Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 13
New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy
Hanna Chowaniec, Antonina Ślubowska, Magdalena Mroczek, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities
Rita Ribeiro, Maria João Carvalho, João Gonçalves, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 36
Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and In Vitro Characterization
Farnosh Darabi, Massoud Saidijam, Fatemeh Nouri, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 31
Ca & Mn dual-ion hybrid nanostimulator boosting anti-tumor immunity via ferroptosis and innate immunity awakening
Xi Deng, Tianzhi Liu, Yutong Zhu, et al.
Bioactive Materials (2023) Vol. 33, pp. 483-496
Open Access | Times Cited: 22
Identification of cuproptosis-related miRNAs in triple-negative breast cancer and analysis of the miRNA–mRNA regulatory network
Yitao Wang, Jundan Wang, Jing Jiang, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28242-e28242
Open Access | Times Cited: 8
Auranofin-Loaded Chitosan Nanoparticles Demonstrate Potency against Triple-Negative Breast Cancer
Maame Abena O. Afrifa, Jong H. Kim, Kathryn A. Pitton, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 3, pp. 2012-2022
Closed Access | Times Cited: 7
Formononetin Restrains Tumorigenesis of Breast Tumor by Restraining STING-NF-κB and Interfering with the Activation of PD-L1
Hongmei Liu, Zhipeng Wang, Zhigang Liu
Discovery Medicine (2024) Vol. 36, Iss. 182, pp. 613-613
Open Access | Times Cited: 7
Recent advancement in breast cancer treatment using CAR T cell therapy:- A review
Anuvab Dey, Subhrojyoti Ghosh, Shreya Jha, et al.
Advances in Cancer Biology - Metastasis (2023) Vol. 7, pp. 100090-100090
Open Access | Times Cited: 14
Identification of the tumor metastasis-related tumor subgroups overexpressed NENF in triple-negative breast cancer by single-cell transcriptomics
Guixin Wang, Cangchang Shi, Long He, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Lysine-Specific Demethylase 1 (LSD1)-Mediated Epigenetic Modification of Immunogenicity and Immunomodulatory Effects in Breast Cancers
Dong Yeul Lee, Talha Salahuddin, Jabed Iqbal
Current Oncology (2023) Vol. 30, Iss. 2, pp. 2127-2143
Open Access | Times Cited: 13
Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes
Kelsee K. Zajac, Saloni Malla, R. Jayachandra Babu, et al.
Cancer Reports (2023) Vol. 6, Iss. S1
Open Access | Times Cited: 12
Targeting myeloid-derived suppressor cells in combination with tumor cell vaccination predicts anti-tumor immunity and breast cancer dormancy: an in silico experiment
Reza Mehdizadeh, Seyed Peyman Shariatpanahi, Bahram Goliaei, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Advancing immunotherapy in triple negative breast Cancer: A novel multimodal theranostic nanoplatform integrating synergetic ferroptosis and photothermal therapy
Long Cheng, Yi‐Bo Qiu, Ling‐Yun He, et al.
Chemical Engineering Journal (2024) Vol. 485, pp. 150057-150057
Closed Access | Times Cited: 4
Present and Future of Immunotherapy for Triple-Negative Breast Cancer
Sushmitha Sriramulu, Shivani Thoidingjam, Corey Speers, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3250-3250
Open Access | Times Cited: 4
Disruption of RBMS3 suppresses PD-L1 and enhances antitumor immune activities and therapeutic effects of auranofin against triple-negative breast cancer
Yuting Zhou, Zhongping Liang, Yingjie Xia, et al.
Chemico-Biological Interactions (2022) Vol. 369, pp. 110260-110260
Closed Access | Times Cited: 18
Immunoinformatics Approach for Epitope-Based Vaccine Design: Key Steps for Breast Cancer Vaccine
Aisyah Fitriannisa Prawiningrum, Rafika Indah Paramita, Sonar Soni Panigoro
Diagnostics (2022) Vol. 12, Iss. 12, pp. 2981-2981
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top